ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Characteristics of Patients with Early vs Late BK Viremia after Kidney Transplantation

S. Rehman1, J. Pryor2, A. Olyaei3, M. Stack1, D. Norman1, J. Lockridge1

1Medicine/Nephrology, Oregon Health and Science University, Portland, OR, 2Oregon Health and Science University, Portland, OR, 3Pharmacy, Oregon Health and Science University, Portland, OR

Meeting: 2019 American Transplant Congress

Abstract number: C268

Keywords: Polyma virus

Session Information

Date: Monday, June 3, 2019

Session Name: Poster Session C: Kidney: Polyoma

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Hall C & D

Related Abstracts
  • Slipping Through the Cracks: Late Onset BK Viremia.
  • Better Never Than Late: Differences in Outcomes and Risk Factors for Early and Late Rejection After Kidney Transplantation.

*Purpose: To describe the characteristics of patients presenting with late BK viremia (>1 year after transplant) and compare to early BK viremia

*Methods: This study was approved by the Institutional Review Board. Between Jan 2010 and Dec 2016, 523 recipients had a kidney transplant at our institution with a minimum of 1 year follow up. All patients were monitored for BK viremia per center protocol. For patients with positive serum BK PCR, their immunosuppression dose was reduced. We reviewed complete information about recipient’s immunosuppressive medications, type of induction, age, etiology of kidney disease, dialysis modalities, cold and warm ischemic times, gender, ethnicity, donor and recipient CMV serostatus, and biopsy-proven acute rejection. We compared recipients developing BK viremia early [within 12 months after transplant] vs late [more than 12 months after transplant]. We described BK viremia in regard to time to first onset of BK viremia, time to clearance of BK viremia, and duration of ongoing BK viremia.

*Results: The initial analysis included 523 patients, 130 of whom developed BK viremia and 22 who developed BK viruria alone. Viruria alone was excluded from further analysis. Upon analysis of baseline characteristics between the early and late viremia groups, we could not detect any differences in age, race, sex, type of induction, maintenance immunosuppression or donor type between early and late groups. There was no difference between mean serum creatinine, time to clear BK virus nor median peak viral load. Those that developed late BK were less likely to clear the infection: clearance rates were 82% vs 59%(p=0.000175). We noted only one incidence of acute rejection (6%) after reduction of immunosuppression in the late BK viremia group, vs 19 after reduction in the early BK viremia group (16%).

Early (n=113) Late (n=17) P Value
Rejection (%) 35% 29% 0.026
Mean SCr at 12 months 1.3 1.18 0.2639
BK clearance (%) 82% 59% 0.000175
Time to onset of BK viremia (days) 108 462 <0.0001
Time to clear BK viremia (days) 215 131 0.189
Median Peak Viral Load 249,525 25,855 0.34
Duration of viremia (days) 704 428 0.03

*Conclusions: While we could not detect any differences in characteristics between patients presenting with BK viremia early vs late in their post transplant course, we noted that patients who presented late had a lower incidence of clearing the infection, possibly due to late detection, and a lower incidence of rejection after immunosuppression reduction. Our data suggests that patients should be monitored beyond one year for BK viremia, although the clinical significance of late BK viremia is not fully understood.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Rehman S, Pryor J, Olyaei A, Stack M, Norman D, Lockridge J. Characteristics of Patients with Early vs Late BK Viremia after Kidney Transplantation [abstract]. Am J Transplant. 2019; 19 (suppl 3). https://atcmeetingabstracts.com/abstract/characteristics-of-patients-with-early-vs-late-bk-viremia-after-kidney-transplantation/. Accessed March 4, 2021.

« Back to 2019 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Penis Transplantation: First U.S. Experience.
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.